[22] |
AD |
GAPDH |
Interaction with β-amyloid precursor protein [22] |
Various |
[24] |
AD |
Respiratory mitochondrial complex subunits including those from the NDUFA and NDUFB subunits of the enzyme NADH dehydrogenase |
Mitochondrial proteomic differences in early-onset and late-onset AD [24] |
Brain tissue |
Multiple studies: Moya-Alvarado et al. [25–27] |
AD |
Proteins associated with mitochondria, phosphorylation and oxidation |
Impaired glucose metabolism and energy production [25–27] |
Multiple studies from blood and brain tissue |
Hondius et al. [28] |
AD |
Calcium-dependent signaling proteins, extracellular matrix components |
Protein expression changes in hippocampus [28] |
Brain |
[138] |
AD |
Novel peptide sequences identified (SpotLight) |
Antibody variable region associations with potential to provide disease origin insights [138] |
Blood |
[29] |
AD |
Reduced glucose utilization |
Biomarker for AD detection [29] |
Brain |
Bot et al./Netherlands Study of Depression and Anxiety |
MDD |
171 serum proteins and serum analytes |
Linked to diverse cell communication, signal transduction processes, immune response and protein metabolism [30] |
Serum |
Gellen et al.
|
MDD |
Changes in protein abundance |
Linked to several biological functions, including inflammation, transcription, cell metabolism and cytoskeleton organization [31] |
Animal model |
Comes et al. [139] |
MDD |
141 peptides and analytics analytes with combined m/z 1017, m/z 1042 and m/z 1479 |
Potential biomarkers |
Blood |
Multiple studies: [32, 140]; [7, 32] |
MDD |
DPYSL2 also known as CRMP2; CA2 and ALDOC |
Regulating axonal guidance, neuronal growth cone collapse and cell migration [32, 140]; energy metabolism [7, 32] |
Studies from blood and brain tissue |
[32] |
MDD versus SCZ |
HINT1 increased in MDD and lower in SCZ. |
Differential protein levels in brain of MDD and SCZ patients |
Blood and urine |
[139] |
BD |
Alpha-2-macroglobulin, Apolipoprotein A-I and C4b-binding protein alpha chain, Complement C3, Glutathione-S-transferase A3, hemopexin, Immunoglobulin M, Kit ligand, Macrophage migration inhibitory factor, MMP7 and sex hormone-binding globulin |
Proteins belonging to the following pathways associated with BD: FXR/RXR activation, LXR/RXR activation, acute phase response signaling, clathrin-mediated endocytosis signaling and atherosclerosis signaling |
Blood |
Ren et al. [34] |
BD versus MDD |
Proteins upregulated: B2RAN2, B4E1B2, APOA1, ENG, SBSN and QSOX2. Proteins downregulated: ORM1, MRC2 and SLPI downregulated |
B2RAN2 and ENG as potential biomarkers to differentiate BD and MDD |
Blood plasma |
Ristori et al. [10] |
ASD |
(APOE and APOA1) and (FN1) |
Large presence of apolipoproteins proteins and fibronectin |
Studies from blood and brain tissue |
Junaid et al. [141] |
ASD |
Glyoxalase I (Glo1) [141] |
Increase in polarity |
Brain |
[35] |
SCZ, ASD and BD |
p140Cap protein interactome network associated with the SRCIN1 gene |
Common interactome network |
Various |